<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00718939</url>
  </required_header>
  <id_info>
    <org_study_id>360014</org_study_id>
    <nct_id>NCT00718939</nct_id>
  </id_info>
  <brief_title>Rheos® Diastolic Heart Failure Trial</brief_title>
  <official_title>Rheos® Diastolic Heart Failure Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CVRx, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CVRx, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The CVRx® Rheos® Diastolic Heart Failure Trial is a prospective, randomized, double blind
      trial with up to 60 subjects conducted at up to five centers in Europe. All subjects will be
      followed up to one year post implant.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess left ventricular mass index (LVMI).</measure>
    <time_frame>at six months post- randomization.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess safety by evaluating all adverse events.</measure>
    <time_frame>through six months post -implant</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess difference between randomization groups in blood pressure changes, blood levels and quality of life.</measure>
    <time_frame>six months post-implant</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Diastolic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Rheos ON</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Study participants in this arm will have the device turn on for six months and remains on.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rheos OFF</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Study participants in this arm will have the device turned off for 6 months and then turned on.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rheos Baroreflex Activation Therapy System</intervention_name>
    <description>The two (2) Rheos Carotid Sinus Leads conduct the activation energy from the Rheos Implantable Pulse Generator to the baroreceptors located on the left (Left Carotid Sinus Lead) and right (Right Carotid Sinus Lead) carotid sinus. This energy activates the baroreflex by inducing signals that the brain interprets as elevated blood pressure.</description>
    <arm_group_label>Rheos ON</arm_group_label>
    <arm_group_label>Rheos OFF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be at least 21 years of age.

          -  Have bilateral carotid bifurcations that are below the level of the mandible.

          -  Have a left ventricular ejection fraction ≥ 45%.

          -  Clinical Heart Failure with elevated BNP or NT-Pro-BNP.

        Exclusion Criteria:

          -  History of or suspected baroreflex failure or autonomic neuropathy.

          -  History of symptomatic bradyarrhythmias, pericardial constriction, infiltrative
             cardiomyopathy, cardiac valvular disease.

          -  Organ or hematologic transplant.

          -  History of prior surgery, radiation, or stent placement in carotid sinus region.

          -  History of severe chronic kidney disease.

          -  Life expectancy to less than one year.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maximilian A Pichlmaier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medizinische Hoschschule Hannover</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johannes Sperzel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kerckhoff-Klinik Forschungsgesellschaft mbH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Prof. Uta Hoppe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Herbert Naegele, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Krankenhaus Reinbek St.Adolfsstif</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kerckhoff-Klinik Forschungsgesellschaft mbH</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Reinbek St.Adolfsstif</name>
      <address>
        <city>Hamburg-Reinbek</city>
        <zip>21465</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hoschschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Koeln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <removed_countries>
    <country>Netherlands</country>
  </removed_countries>
  <link>
    <url>http://www.cvrx.com</url>
  </link>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2008</study_first_submitted>
  <study_first_submitted_qc>July 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2008</study_first_posted>
  <last_update_submitted>October 19, 2016</last_update_submitted>
  <last_update_submitted_qc>October 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diastolic Heart Failure</keyword>
  <keyword>Cardiac dysfunction</keyword>
  <keyword>Heart Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Diastolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

